(rel)-Tivantinib is a potent and highly selective inhibitor of the receptor tyrosine kinase c-MET. (rel)-Tivantinib has two novel targets, GSK3alpha and GSK3beta, which play an important role in the cellular mechanism of non-small cell lung cancer (NSCLC)[1].
Molecular Weight:
369.42
Purity:
96.45
CAS Number:
[905853-99-8]
Formula:
C23H19N3O2
Target:
c-Met/HGFR
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted